<VariationArchive RecordType="classified" VariationID="1558" VariationName="LPL, 1-BP DEL, CODON 172" VariationType="Deletion" Accession="VCV000001558" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-09-24" DateCreated="2018-07-02" MostRecentSubmission="2018-07-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="16597" VariationID="1558">
      <GeneList>
        <Gene Symbol="LPL" FullName="lipoprotein lipase" GeneID="4023" HGNC_ID="HGNC:6677" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>8p21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="19939253" stop="19967259" display_start="19939253" display_stop="19967259" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="19796581" stop="19824769" display_start="19796581" display_stop="19824769" Strand="+" />
          </Location>
          <OMIM>609708</OMIM>
        </Gene>
      </GeneList>
      <Name>LPL, 1-BP DEL, CODON 172</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8p22</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>1-BP DEL, CODON 172</Name>
      </OtherNameList>
      <XRefList>
        <XRef Type="Allelic variant" ID="609708.0041" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff could not provide an HGVS expression for allelic variant 609708.0041 because the numbering system was not specified and the primary sequence data were not reported in the paper by Pruneta-Deloche et al. 2005 (PubMed 15840743).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="LPL, 1-BP DEL, CODON 172 AND Hyperlipoproteinemia, type I" Accession="RCV000001624" Version="4">
        <ClassifiedConditionList TraitSetID="396">
          <ClassifiedCondition DB="MedGen" ID="C0023817">Hyperlipoproteinemia, type I</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2005-07-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-07-02" MostRecentSubmission="2018-07-02">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15840743</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="396" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2362" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hyperlipoproteinemia, type I</ElementValue>
                <XRef ID="Hyperlipoproteinemia+type+1/3574" DB="Genetic Alliance" />
                <XRef ID="275598004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lipase D deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERLIPOPROTEINEMIA, TYPE IA</ElementValue>
                <XRef Type="MIM" ID="238600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial hyperlipo-proteinemia type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipemia essential familial</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial Lipoprotein Lipase Deficiency</ElementValue>
                <XRef ID="238086005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipoproteinemia type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lipoprotein lipase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">LPL deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperchylomicro-nemia familial</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial chylomicronemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipemia idiopathic Burger-Grutz type</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000030379" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511673" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558518" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511672" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507679" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558516" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Familial lipoprotein lipase (LPL) deficiency usually presents in childhood and is characterized by very severe hypertriglyceridemia with episodes of abdominal pain, recurrent acute pancreatitis, eruptive cutaneous xanthomata, and hepatosplenomegaly. Clearance of chylomicrons from the plasma is impaired, causing triglycerides to accumulate in plasma and the plasma to have a milky (lactescent or lipemic) appearance. Symptoms usually resolve with restriction of total dietary fat to =20 g/day.</Attribute>
                <XRef ID="NBK1308" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12241" />
                <XRef ID="12241" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301485</ID>
                <ID Source="BookShelf">NBK1308</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ES, 2012">
                <ID Source="PubMed">22962670</ID>
                <ID Source="pmc">3431581</ID>
              </Citation>
              <XRef ID="309015" DB="Orphanet" />
              <XRef ID="444490" DB="Orphanet" />
              <XRef ID="C0023817" DB="MedGen" />
              <XRef ID="MONDO:0009387" DB="MONDO" />
              <XRef Type="MIM" ID="238600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="21780" SubmissionDate="2018-06-29" DateLastUpdated="2018-07-02" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="609708.0041_LIPOPROTEIN LIPASE DEFICIENCY" title="LPL, 1-BP DEL, CODON 172_LIPOPROTEIN LIPASE DEFICIENCY" />
        <ClinVarAccession Accession="SCV000021780" DateUpdated="2018-07-02" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with LPL deficiency (238600) and severe hypertriglyceridemia with recurrent pancreatitis, Pruneta-Deloche et al. (2005) detected a heterozygous 1-bp deletion at the second nucleotide of codon 172 of lipoprotein lipase, which resulted in frameshift, premature termination (Ser172fsTer179), and an inactive peptide. The mutation was associated with an antihuman LPL IgG. This autoantibody partially inhibited wildtype LPL activity in vitro. Furthermore, the patient's plasma triglyceride concentrations were efficiently decreased under immunosuppressive treatment, and this was confirmed by sequential withdrawal/reintroduction tests. The patient presented with severe unmanageable type V hyperlipoproteinemia with fasting chylomicronemia.</Attribute>
              <Citation>
                <ID Source="PubMed">15840743</ID>
              </Citation>
              <XRef DB="OMIM" ID="238600" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LPL" />
          </GeneList>
          <Name>LPL, 1-BP DEL, CODON 172</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, CODON 172</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="609708.0041" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LIPOPROTEIN LIPASE DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="21780" TraitType="Disease" MappingType="Name" MappingValue="LIPOPROTEIN LIPASE DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C0023817" Name="Hyperlipoproteinemia, type I" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

